Biohaven BHVN
NYSE BHVN
$12.87 -0.27 (-2.05%)
As of: Oct 2, 2026 · 3:59 PM EDT

Biohaven (BHVN) Cash from Financing Activities (2021 - 2026)

Updated

Biohaven's Cash from Financing Activities was $3.8 million in Q2 2026, down 98.5% from $249.83 million a year earlier and down 97.9% from the prior quarter.

Analysis

Biohaven (BHVN) Cash from Financing Activities (2021 - 2026) Analysis & Trends

On a trailing twelve-month basis, Biohaven's Cash from Financing Activities was $371.73 million through Jun 30, 2026, down 38.4% year-over-year; for FY2025, it was $439.12 million, down 35.2% from FY2024.

  • Cash from Financing Activities shows a five-year compound annual growth rate of 23.6% (FY2020 to FY2025).
  • In earlier years, Cash from Financing Activities was $677.77 million in FY2024 (+219.8%), $211.91 million in FY2023 (-72.4%), $767.6 million in FY2022 (+454.4%) and $138.45 million in FY2021 (-9.1%).
  • Quarterly Cash from Financing Activities has moved between -$252.39 million (Q4 2021) and $530.18 million (Q4 2022) over five years.
  • Compared with a year earlier, Cash from Financing Activities was higher in 1 of the last six quarters, with an average decline of 54.9%.
  • The best year-over-year quarter for Cash from Financing Activities over five years was Q1 2023 (growth of 15.8%); the worst was Q3 2025 (a decline of 99.8%).
  • Per Business Quant data, BHVN's Cash from Financing Activities in the three quarters before Q2 2026 was $179.02 million (Q1 2026), $188.8 million (Q4 2025) and $122,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Biohaven 2.01 Bn 819.54 Mn - 3.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.80 Mn
Mar 31, 2026 179.02 Mn
Dec 31, 2025 188.80 Mn
Sep 30, 2025 122,000.00
Jun 30, 2025 249.83 Mn
Mar 31, 2025 369,000.00
Dec 31, 2024 272.85 Mn
Sep 30, 2024 80.38 Mn
Jun 30, 2024 321.12 Mn
Mar 31, 2024 3.42 Mn
Dec 31, 2023 245.24 Mn
Sep 30, 2023 -39.66 Mn
Jun 30, 2023 -20.34 Mn
Mar 31, 2023 26.67 Mn
Dec 31, 2022 530.18 Mn
Sep 30, 2022 127.54 Mn
Jun 30, 2022 86.84 Mn
Mar 31, 2022 23.03 Mn
Dec 31, 2021 -252.39 Mn
API Access

Biohaven Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=BHVN&period=max&api_key=YOUR_API_KEY